SNTI - Senti Biosciences GAAP EPS of -$0.42 revenue of $0.93M August, 11 2023 10:41 AM Senti Biosciences Inc. 2023-08-11 10:41:32 ET Senti Biosciences press release ( NASDAQ: SNTI ): Q2 GAAP EPS of -$0.42. Revenue of $0.93M (-31.1% Y/Y). For further details see: Senti Biosciences GAAP EPS of -$0.42, revenue of $0.93M